• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Serine/threonine-protein kinase 40 (STK40)

ACP12836

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP12836 Target NameSTK40
Target SynonymsSTK40; SGK495; SHIK; Serine/threonine-protein kinase 40; EC 2.7.11.1; SINK-homologous serine/threonine-protein kinase; Sugen kinase 495; SgK495FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-435
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8N2I9
Background Information
  • Uniprot Id

    Q8N2I9

  • Target Species

    Human

  • Target Name

    STK40

  • Target Full Name

    Serine/threonine-protein kinase 40

  • Target Function

    May be a negative regulator of NF-kappa-B and p53-mediated gene transcription.

  • Target Subcellular Location

    Nucleus. Cytoplasm.

  • Target Protein Families

    Protein kinase superfamily, CAMK Ser/Thr protein kinase family

  • Target Tissue Specificity

    Strongly expressed in heart, brain, placenta, lung, skeletal muscle, kidney, spleen, thymus, prostate, liver, pancreas, testis, ovary, small intestine, colon and peripheral blood leukocytes.

  • Target Synonyms

    STK40; SGK495; SHIK; Serine/threonine-protein kinase 40; EC 2.7.11.1; SINK-homologous serine/threonine-protein kinase; Sugen kinase 495; SgK495

Inquire Recombinant Human Serine/threonine-protein kinase 40 (STK40) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification